Systemic sclerosis & Raynaud's

Chemokine receptor CXCR4 based positron emission tomography imaging in systemic sclerosis-related interstitial lung disease

Rheumatology (Oxford)Published Cross-sectional study

Authors' conclusion

In SSc-ILD, CXCR4 expression is upregulated in both lung parenchyma and peripheral T cells, significantly in progressive and UIP subsets.

Study context

Population
Patients with SSc-ILD
Exposure
SSc-ILD patients vs controls
Outcome
Whole-lung CXCR4 uptake on PET, median SUVmean
Methodological detailsPositron emission tomography (PET) imaging (68Ga-CPCR4), flow cytometry, subset analysis
  • PET imaging (68Ga-CPCR4)
  • Flow cytometry
  • Subset analysis

Main finding

As reported in the abstract

SSc-ILD

0.56

median

P < 0.0001

Highest AUC in dorsobasal regions
0.91
Highest AUC in reticular with architecturally distorted areas
0.95

Observational data: associations, not effects.

Further findings

Median

OutcomeProgressiveEarlyStableP value
Whole-lung median SUVmean by clinical subsetProgressive vs Early0.730.490.45P < 0.0001
Whole-lung median SUVmean by clinical subsetProgressive vs StableP < 0.0001
CXCR4 uptake by ILD pattern · UIP vs NSIP · higher uptake in UIP
P = 0.0032
Peripheral CXCR4+ T cells, SSc-ILD vs controls · higher CD4+CXCR4+ T cells
P = 0.0003
Peripheral CXCR4+ T cells, SSc-ILD vs controls · higher CD8+CXCR4+ T cells
P = 0.0013

Whole-lung median SUVmean by clinical subset

Progressive subset had higher AUC than early and stable subsets

CXCR4 uptake by anti-Scl70 status

Trend for higher uptake in anti-Scl70 positive vs negative patients

Peripheral CXCR4+ T cells, SSc-ILD vs controls

Moderate to strong correlation with lung parenchymal regions

Original publication

Chemokine receptor CXCR4 based positron emission tomography imaging in systemic sclerosis-related interstitial lung disease. Rheumatology (Oxford). Published 23 September 2024. doi:10.1093/rheumatology/keae503

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.